|
Volumn 24, Issue 3, 2002, Pages 139-144
|
Involvement of opioid delta (δ)- and kappa (κ)-receptors in ischemic preconditioning in a rat model of myocardial infarction
|
Author keywords
DADLE; Myocardial infarction; Natrindole; Nor BNI; Opioid and receptors; Radioligand receptor study; U 50488H
|
Indexed keywords
3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE;
DELTA OPIATE RECEPTOR;
DELTA OPIATE RECEPTOR AGONIST;
DELTA OPIATE RECEPTOR ANTAGONIST;
ENKEPHALIN;
ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE];
ENKEPHALIN[2,5 DEXTRO PENICILLAMINE];
KAPPA OPIATE RECEPTOR;
KAPPA OPIATE RECEPTOR AGONIST;
KAPPA OPIATE RECEPTOR ANTAGONIST;
NALTRINDOLE;
NORBINALTORPHIMINE;
3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE;
ACUTE HEART INFARCTION;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
ELECTROCARDIOGRAPHY MONITORING;
ENZYME ASSAY;
HEART ARRHYTHMIA;
HEART INFARCTION PREVENTION;
HEART INFARCTION SIZE;
HEART MUSCLE CELL;
HEART VENTRICLE EXTRASYSTOLE;
MALE;
MORPHOMETRICS;
MORTALITY;
NONHUMAN;
PROTEIN EXPRESSION;
PROTEIN SECRETION;
RAT;
RECEPTOR AFFINITY;
RECEPTOR DENSITY;
RECEPTOR DOWN REGULATION;
ANALYSIS OF VARIANCE;
ANIMAL;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG POTENTIATION;
HEART INFARCTION;
HEART MUSCLE;
HEMODYNAMICS;
IN VITRO STUDY;
METABOLISM;
PATHOLOGY;
PATHOPHYSIOLOGY;
RADIOASSAY;
WISTAR RAT;
3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER;
ANALYSIS OF VARIANCE;
ANIMAL;
DISEASE MODELS, ANIMAL;
HEMODYNAMICS;
IN VITRO;
ISCHEMIC PRECONDITIONING, MYOCARDIAL;
MALE;
MYOCARDIAL INFARCTION;
MYOCARDIUM;
RADIOLIGAND ASSAY;
RATS;
RATS, WISTAR;
RECEPTORS, OPIOID, DELTA;
RECEPTORS, OPIOID, KAPPA;
ANIMALS;
HEMODYNAMIC PROCESSES;
|
EID: 0035989669
PISSN: 03790355
EISSN: None
Source Type: Journal
DOI: 10.1358/mf.2002.24.3.802298 Document Type: Article |
Times cited : (22)
|
References (34)
|